Maintenance Notice (3:15 - 7:30 AM February 22, 2025 UTC): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Notice of Discontinuing the Use of Password-Protected Compressed Files | Product Document Searching Made Easy by 2D Code! | TCI Life Science News February 2025 | [Product Highlights] Chemiluminescent Reagents for... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 72558-82-8 | Product Number: C2225
Ceftazidime (contains ca. 10% Na2CO3)
×
![]()
×
Purity:
Synonyms:
- CAZ (contains ca. 10% Na2CO3)
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 5G |
$82.00
|
≥60 | ≥80 | It can be shipped in about 2 weeks after ordering | |
| 25G |
$247.00
|
15 | 1 | It can be shipped in about 2 weeks after ordering |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product has not been tested for potency and is guaranteed for chemical purity.
| Product Number | C2225 |
| Molecular Formula / Molecular Weight | C__2__2H__2__2N__6O__7S__2 = 546.57 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 72558-82-8 |
| Reaxys Registry Number | 4344904 |
| PubChem Substance ID | 87560561 |
| Merck Index (14) | 1946 |
| MDL Number | MFCD00072034 |
Specifications
| Appearance | White to Orange to Green powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Specific rotation [a]20/D | -22.0 to -26.0 deg(C=0.5, pH6.0 Phosphate Buffer) |
| Drying loss | max. 14.0 % |
| Ignition residue(Sulfate) | 10.0 to 15.0 % |
Properties (reference)
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H317 : May cause an allergic skin reaction. H334 : May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P272 : Contaminated work clothing should not be allowed out of the workplace. P280 : Wear protective gloves. P284 : Wear respiratory protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P342 + P311 : If experiencing respiratory symptoms: Call a POISON CENTER/doctor. P362 + P364 : Take off contaminated clothing and wash it before reuse. P304 + P340 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. |
Related Laws:
| RTECS# | UU2225000 |
Transport Information:
| H.S.code* | 2941.90-000 |
Application
Ceftazidime: A Third Generation Semisynthetic Cephalosporin Antibiotic with Activity against Pseudomonas aeruginosa
Ceftazidime is a third generation semisynthetic cephalosporin antibiotic, which is chemically synthesized form
7-aminocephalosporanic acid (7-ACA) [A1266]. It has broad spectrum activity against Gram-positive and Gram-negative bacteria, however has weaker activity against Gram-positive bacteria. Furthermore, it is different from other cephalosporins by virtue of its activity against Pseudomonas aeruginosa.
7-aminocephalosporanic acid (7-ACA) [A1266]. It has broad spectrum activity against Gram-positive and Gram-negative bacteria, however has weaker activity against Gram-positive bacteria. Furthermore, it is different from other cephalosporins by virtue of its activity against Pseudomonas aeruginosa.
References
- The Activity of Ceftazidime Compared with Those of Aztreonam, Newer Cephalosporins and Sch 29482 against Nonfermentative Gram-Negative Bacilli
- Ceftazidime (an update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy)
- In-vitro comparative study of Cefoperazone, Ceftazidime, Ceftizoxime, Cefotaxime, Ceftriaxone and Cefixime against Pseudomonas aeruginosa
- Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.